sevenspikes.themes.common.filters
sevenspikes.themes.common.closemenu

SC-58125,≥98% (HPLC)

别名:5-(4-氟苯基)-1-[4-(甲基磺酰基)苯基]-3-(三氟甲基)吡唑;SC58125;5-(4-Fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)pyrazole

Empirical Formula (Hill Notation): C17H12N2SO2F4 CAS号: 162054-19-5 分子量: 384.35 MDL编号: MFCD00930300 PubChem化学物质编号: 329823724 NACRES: NA.77
制造商品牌: 西格玛 Sigma-Aldrich
货号(SKU): PZ0139
CAS号: 162054-19-5
MDL号: MFCD00930300
增值税发票 √ 免费送货 √ 订货电话:010-68689484
$248.90

说明

包装

5, 25 mg in glass bottle
 

生化/生理作用

SC-58125 is a selective cyclooxygenase 2 (COX-2) inhibitor.
SC-58125 是一种选择性环氧合酶 2 (COX-2) 抑制剂。
 

特点和优势

This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®1280), a biologically annotated collection of high-quality, ready-to-screen compounds. Click here to learn more.
This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®Pfizer), a collection of 90 Pfizer-developed drugs and research tools. Click here to learn more.
 

其他说明

This compound was developed by Pfizer for Lipid Signaling research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.

To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
 

法律信息

Sold for research purposes under agreement from Pfizer Inc.
LOPAC is a registered trademark of Sigma-Aldrich Co. LLC
Pfizer is a registered trademark of Pfizer, Inc.
 

属性

质量水平

100

测定

≥98% (HPLC)

形式

powder

mfr. no.

Pfizer®

颜色

white to off-white

溶解性

DMSO: ≥20 mg/mL

创始人

Pfizer

储存温度

room temp

SMILES string

CS(=O)(=O)c1ccc(cc1)-n2nc(cc2-c3ccc(F)cc3)C(F)(F)F

InChI

1S/C17H12F4N2O2S/c1-26(24,25)14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3

InChI key

JHBIMJKLBUMNAU-UHFFFAOYSA-N

 

安全信息

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

商品规格
属性名称属性值
储存温度 Storage temp.常温阴凉避光
全球实时库存 Availability √美国St. Louis ≥ 33 | 欧洲Eur. ≥ 27 | 東京Tokyo ≥ 9 | 香港与北京 ≥ 16